Evidence map›Paper›PMID 36010214›Full record

GuidelineDiagnostics (Basel, Switzerland)2022

Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up.

Edoardo Brauner, Valentino Valentini, Umberto Romeo, Marco Cantore, Federico Laudoni, Oriana Rajabtork Zadeh, Valeria Formisano, Andrea Cassoni, Marco Della Monaca, Andrea Battisti and 10 more

Open access · goldAbstract readGuideline
In one paragraph

Guideline in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Edoardo BraunerDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.ORCID 0000-0001-7654-482X
Valentino ValentiniDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Umberto RomeoDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.ORCID 0000-0003-2439-2187
Marco CantoreIndependent Researcher, Corso Italia 19, 58015 Orbetello, Italy.
Federico LaudoniIndependent Researcher, via Garibaldi 141, 00012 Guidonia, Italy.
Oriana Rajabtork ZadehDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Valeria FormisanoIndependent Researcher, via Raffaele Cadorna 29, 00187 Rome, Italy.
Andrea CassoniDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.ORCID 0000-0001-6647-504X
Marco Della MonacaDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Andrea BattistiDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Silvia MeziDepartment of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-4746-2678
Alessio CirilloDepartment of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-0449-9569
Francesca De FeliceDepartment of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-5119-8358
Andrea BotticelliDepartment of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
Vincenzo TomboliniDepartment of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5359-9991
Marco De VincentiisDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Andrea ColizzaDepartment of Sense Organs, Policlinico Umberto 1 Sapienza University of Rome, viale Regina Elena 326, 00161 Roma, Italy.ORCID 0000-0002-0639-806X
Gianluca TenoreDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.ORCID 0000-0001-9963-8052
Antonella PolimeniDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.ORCID 0000-0002-2679-7607
Stefano Di CarloDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Sapienza University of Rome · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Patients with head and neck cancer are treated by ablative surgery, radiotherapy, chemotherapy, or a combination of these. The side effects of cancer therapies can compromise conventional prosthesis rehabilitation; therefore, dental implants can result in a more effective solution. The aim of the study is to explain how to rehabilitate a patient that underwent head and neck cancer therapy. (2) Methods: This retrospective study conducted from 2015 to 2021 included 223 postoncological patients, aged between 32 and 80 years old. Eighteen patients did not proceed with any treatment, and two died. Therefore, 203 patients have been analyzed and rehabilitated following our decisional protocol, with a mean period of follow-up of 4 years. The implant placement was considered successful when a mean bone loss of 1.6 mm for the first year and a mean of 0.13 mm in subsequent years occurred (3) Results: A total of 161 patients were rehabilitated with a conventional prosthesis, 42 patients (F:M ratio 19:23) with an implant-supported prosthesis and a total of 200 implants were placed; 9 implants were lost (4.5% of 200 implants). Conclusions: The results confirmed that by following our protocol it is possible to obtain an acceptable rate of implant survival, considering the delicacy and complexity of post-oncological patients.

Indexed as

decisional protocoldental implant risk failurepostoncological patients

Identifiers

PMID36010214
PMCPMC9406984
OpenAlexW4289519508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.